News ArchivesRead News

Your Parkinson's News Update for the Week of 11.2.20

Monday November 02, 2020
Making Drugs For Parkinson’s From Food Waste:
Scientists Discover An Environmentally Friendly Way
To Turn Waste Into Products
National University of Singapore via Forbes
Researchers at National University of Singapore have figured out a way to use food waste to derive L-Dopa to treat Parkinson’s and amino acid essential for collagen production.
"It is no secret that food waste is in abundance in our world, in the US alone there is 80 billion pounds of food waste each year. Although food waste may seem harmless, it has grave consequences for the environment, with global food waste contributing to 6% of greenhouse gas emissions. In addition to that, it has economic implications as the food waste equates, in 2010 the loss due to waste and food loss was $162 billion. But what if we can reverse this and turn waste in products we need?"
COVID-19 May Raise Risk of Developing Parkinson’s
Trends in Neuroscience via New York Post
Some side effects of COVID-19 — including blood clotting, inflammation, and a weakened nervous system — could make patients more vulnerable to the brain disorder, researchers from Van Andel Institute warned in the study, published in the journal Trends in Neurosciences.
“COVID-19 is clearly a major and ongoing public health threat, but the consequences of infection may end up being with us for years and decades to come,” Patrik Brudin, director of the Center for Neurodegenerative Science at the Institute, said in a press release describing the virus as a “perfect storm” for Parkinson’s.
What Is Deep Brain Stimulation,
and Why Does It Work for Parkinson's?
Discover Magazine
The brain surgery sounds like science fiction, but at this point it is far from unheard-of. Deep brain stimulation (DBS) is a growing field in neurosurgery that has given hope to people with debilitating conditions.
The implantation of electrodes in the brain has been used by clinicians since the 1930s, most notably by neurosurgeon Wilder Penfield, who initially used this method to treat patients with epilepsy. By 1987, a neurosurgical team in Grenoble, France, developed the modern-day version of DBS as an effective way to treat essential tremor and Parkinson’s. According to a 2019 paper published Nature, more than 160,000 patients from all over the world have benefited from DBS to treat a variety of conditions.